Annenberg Center for Health Sciences At Eisenhower

13/06/2024

Out interprofessional faculty share their real-world experience as they discuss the etiology, diagnosis, staging, and treatment of patients with neurotrophic keratitis. In addition to an overview of symptomatic care and emerging treatments, the safety, efficacy, storage, and administration of cenegermin are explained in detail. Clinical and real-world questions are discussed, related to patient education, provided by the interprofessional, multidisciplinary team.
https://annenberg.net/courses/landingPage.php?courseID=60880

10/06/2024

Join Mary Kay Koenig, MD, in this free CME activity as she explains TK2d's clinical presentation through real case studies. Dr. Koenig offers guidance on diagnosing mitochondrial diseases, discusses the criteria for referring patients to specialized mitochondrial centers, explores vital aspects of supportive care, and shares insights into a novel therapy providing hope for the future of TK2d treatment. Don't miss this invaluable opportunity to enhance your knowledge and practice.
https://annenberg.net/courses/landingPage.php?courseID=60530

Mary Kay Koenig, MD, a leader in the management of patients with mitochondrial diseases, delves into the complexities of managing patients with thymidine kinase 2 deficiency (TK2d). In this 1-hour activity, Dr. Koenig shares her insights in the clinical presentation of TK2d through real case studies...

06/06/2024

📢 Exciting Announcement! Join us for a free LIVE CE Webcast on Wednesday, June 12th!

Our expert faculty will provide insights on:
✅ Guidelines for complementary feeding
✅ Early allergen introduction for food allergy prevention
✅ Best practices & clinical considerations for early introduction of allergenic foods
✅ Utilizing allergenic foods to enhance diversity during complementary feeding

https://pnce.org/courses/landingPage.php?courseID=6079-IL

08/05/2024

Please join cardiologist Jorge Plutzy, MD,and endocrinologist Helena Rodbard, MD as they navigate through a series of ‘clinical questions’ to inform regarding the clinical pharmacology of the GLP-1RAs and their evidence-based role in cardiovascular risk reduction, particularly in patients with secondary atherosclerotic cardiovascular disease. In this activity, case studies commonly encountered in cardiology practice are utilized to prompt reflection on opportunities for reducing cardiovascular risk. The faculty also provide recommendations to optimize the use of GLP-1RAs as a class, as well as individually, including strategies to mitigate gastrointestinal adverse events and address patient concerns.
https://annenberg.net/courses/landingPage.php?courseID=60520

06/05/2024

We are pleased to offer the following Allergy Presentations this month:

- How to Use Phenotyping to Guide Management of Food Allergy
- Food Allergy Tests Are Not Screening Tests
- Social Media For Clinicians Who Care For Infants
- Instilling Confidence Surrounding Early Introduction of Allergenic Foods
- Food Oral Immunotherapy
- Tackling Allergy Misinformation
- Exploring the Connection Between the Microbiome and Allergy Development

https://pnce.org/Allergy2024

03/05/2024

Join us tomorrow for the symposium, "Emerging Developments in Human Milk Fortification: Problem Solving for Clinical Practice."

-Overcoming challenges to optimal preterm infant nutrition
-Strategic use of donor milk
-Human milk fortification timing and clinical practice strategies
-Influence of feeding types on the preterm microbiome
-Emerging evidence on human milk bioactives

https://pnce.org/toronto

01/05/2024

Discover the intricacies of metabolic dysfunction-associated steatohepatitis (MASH). Join us for a deep dive into this critical topic with a 1-hour journal-style review, complete with insightful videos from expert faculty Drs. Jay Shubrook and Arun Sanyal. They'll share their invaluable insights on the identification, diagnosis, and treatment of MASH in primary care.

https://annenberg.net/courses/landingPage.php?courseID=60571

24/04/2024

The landscape of Chronic Lymphocytic Leukemia (CLL) treatment has undergone a profound transformation with the advent of targeted therapies. Discover the power of utilizing Minimal Residual Disease (MRD) as a treatment response indicator and prognostic marker.

Join our 1-hour online, self-directed activity to embark on a journey through 9 complex real-world clinical decisions. This unique educational experience is designed to actively engage clinicians, advancing their understanding and application of the best evidence and practices in CLL management.

Don't miss this opportunity to elevate your expertise and contribute to the positive transformation in CLL care!

https://annenberg.net/courses/landingPage.php?courseID=60750

18/04/2024

Join us in Toronto for the symposium, "Emerging Developments in Human Milk Fortification: Problem Solving for Clinical Practice."

-Overcoming challenges to optimal preterm infant nutrition
-Strategic use of donor milk
-Human milk fortification timing and clinical practice strategies
-Influence of feeding types on the preterm microbiome
-Emerging evidence on human milk bioactives

https://pnce.org/toronto

05/04/2024

What is MFGM and what are the most important structural components of this complex membrane?

Watch insight from Fayez K. Ghishan, MD, renowned professor of pediatric gastroenterology and nutrition, and endowed
chair in pediatric research.

https://pnce.org/pearls/landingPage.php?courseID=60206

03/04/2024

Tell us about the bioactive proteins in MFGM. What are the benefits and related clinical outcomes?

Watch insight from Fayez K. Ghishan, MD, renowned professor of pediatric gastroenterology and nutrition, and endowed chair in pediatric research.

https://pnce.org/pearls/landingPage.php?courseID=60207

15/03/2024

What does your recent research tell us about how pediatricians utilize specialized formulas for treatment of diagnosed or suspected cow’s milk protein allergy?

Watch insight from Michael J. Wilsey, MD, pediatric gastroenterologist.

https://pnce.org/pearls/landingPage.php?courseID=602016

13/03/2024

In infants with diagnosed or suspected cow’s milk protein allergy, how do the outcomes around symptom relief differ between extensively hydrolyzed formula and amino acid formulas?

Watch insight from Michael J. Wilsey, MD, pediatric gastroenterologist.

https://pnce.org/pearls/landingPage.php?courseID=602015

13/03/2024

Survival outcomes for advanced cholangiocarcinoma remain suboptimal, despite first-line treatment with cytotoxic chemotherapy. A greater understanding of cholangiocarcinoma's pathobiology has illuminated various treatment targets, leading to several treatment advances. In this CE acitvity, medical oncologist Lipika Goyal, MD, MPhil, discusses key concepts in navigating through the selection and use of these agents, including managing associated adverse events, helping shape the management of advanced cholangiocarcinoma to optimize patient care.
https://annenberg.net/courses/landingPage.php?courseID=60480

08/03/2024

Tell us about the bioactive lipids in MFGM. What role do they play in neurodevelopment?

Watch insight from Fayez K. Ghishan, MD, renowned professor of pediatric gastroenterology and nutrition, and endowed chair in pediatric research.

https://pnce.org/pearls/landingPage.php?courseID=60208

06/03/2024

Can you elaborate on the role of the various lipid components in MFGM and how they influence brain and cognitive development?

Watch insight from Fayez K. Ghishan, MD, renowned professor of pediatric gastroenterology and nutrition, and endowed chair in pediatric research.

https://pnce.org/pearls/landingPage.php?courseID=60209

06/03/2024

Dive into the world of Neuromyelitis Optica Spectrum Disorder (NMOSD) with Michael Levy, MD, a leading neuroimmunologist at Massachusetts General Hospital. Join us for a concise yet comprehensive 45-minute educational session where Dr. Levy covers NMOSD pathogenesis, diagnosis criteria, laboratory testing, imaging, and common misdiagnoses. Additionally, he discusses the safety and efficacy of approved and off-label therapy options, offering valuable insights for tailoring treatment plans to suit the unique needs of NMOSD patients.
https://annenberg.net/courses/landingPage.php?courseID=60600

23/02/2024

We’re thrilled to share that our team had an incredible time at the Alliance for Continuing Education in the Health Professions conference. Not only did we soak in the latest trends and insights in healthcare education, but we also had the honor of presenting not one, but THREE posters. We’re grateful for the opportunity to contribute to the conversation and collaborate with our fellow professionals. A huge shoutout to our team for their hard work and commitment. Each poster represents a step forward in our mission to enhance learning experiences and improve patient outcomes.

21/02/2024

Join us for a dynamic 1.5-hour online CE course featuring an interprofessional team of primary care and specialty clinicians who discuss real-world challenges in managing patients with complex dyslipidemia, including elevated lipoprotein a (Lp(a)).

Dive into insightful paired conversations as our expert faculty explore recent cholesterol guidelines, patient risk stratification, and recommended goals for those at risk of atherosclerotic cardiovascular disease.

This program format is designed to foster critical thinking and the application of key concepts to real patient cases, empowering participants to elevate their clinical practice.

https://annenberg.net/courses/landingPage.php?courseID=60560

21/02/2024

Jason J. Luke, MD, discusses the impact of evolving therapies on the disease burden, survival, and treatment tolerability for patients with cutaneous melanoma. Recent clinical trial results and guideline updates for both perioperative and metastatic cutaneous melanoma are reviewed. To provide patient-centric care, Dr. Luke shares his expert insights and recommendations for individualizing treatment selection and sequencing, as well as providing supportive care and adverse event management. https://annenberg.net/courses/landingPage.php?courseID=60620

16/02/2024

What role does extensively hydrolyzed formula (EHF) containing Lactobacillus rhamnosus (LGG) have on symptoms of cow’s milk protein allergy in infants either diagnosed with or presenting with symptoms of CMPA?

Watch insight from Michael J. Wilsey, MD, pediatric gastroenterologist.

https://pnce.org/pearls/landingPage.php?courseID=602014

15/02/2024

Exploring the intricacies of follicular lymphoma, a subtype of non-Hodgkin lymphoma, Jeremy Abramson, MD, delves into the challenges faced by patients and healthcare providers alike. From relapses to multiple lines of therapy, this 1-hour online CE course promises insights into the significant disease burden and the latest advancements in treatment options. Additonally, Dr. Abramson discusses the interprofessional care team approach. Join the conversation and be part of the solution!
https://annenberg.net/courses/landingPage.php?courseID=60650

14/02/2024

How does an infant’s gut microbiome impact the potential for colic/fussiness or the potential for allergy development?

Watch insight from Michael J. Wilsey, MD, pediatric gastroenterologist.

https://pnce.org/pearls/landingPage.php?courseID=602013

09/02/2024

Are the effects of MFGM short-term only, or is there evidence for a long-term benefit?

Watch insight from Fayez K. Ghishan, MD, renowned professor of pediatric gastroenterology and nutrition, and endowed chair in pediatric research.

https://pnce.org/pearls/landingPage.php?courseID=602010

07/02/2024

What is omega-3 DHA and why is it important for brain development?

Watch insight from John A. Colombo, PhD, professor of psychology.

https://pnce.org/pearls/landingPage.php?courseID=60201

19/01/2024

What can you share with us in regards to the role of various feeding options in short-term symptom relief and improvement in infants presenting with fussiness, colic, and symptoms of cow’s milk protein allergy?

Watch insight from Michael J. Wilsey, MD, pediatric gastroenterologist.

https://pnce.org/pearls/landingPage.php?courseID=602012